Loading data for SNTI — first visit, this takes a few seconds.
Senti Biosciences Holdings, Inc. (SNTI)
NasdaqCM: SNTI
· Real-Time Price · USD
0.34
+0.00 (0.00%)
At close: Sep 02, 2026, 8:00 PM
0.36
+4.30%
After-hours: 7:34 PM
The price, the headline numbers and the latest news, in one place.
Senti Biosciences Holdings, Inc. (SNTI) Stock Price, Analysis & Data
No data available
| Bid | 0.24 |
| Market Cap | 10.6M |
| Revenue (ttm) | 55K |
| Net Income (ttm) | -49.6M |
| 2.11 | |
| -1.7 | |
| n/a | |
| -0.36 | |
| P/B (ttm) | -3.14 |
| P/S (ttm) | 193.61 |
| Earnings Date | n/a |
| Ask | 0.45 |
| Volume | 39,630 |
| Avg. Volume (20D) | 257,356 |
| Open | 0.34 |
| Previous Close | 0.34 |
| Day's Range | 0.34 - 0.36 |
| 52-Week Range | 0.33 - 2.88 |
| Analyst | n/a |
| Price Target | n/a |
| Dividends | n/a |
| Ex-Dividend Date | n/a |
About SNTI
Senti Biosciences Holdings, Inc., a clinical stage biotechnology company, develops cell and gene therapies engineered with its gene circuit platform technologies for patients living with incurable diseases. The company's lead product candidates utilize off-the-shelf healthy adult donor derived natural killer (NK) cells to create CAR-NK cells outfitted with gene circuit technologies in various oncology indications with unmet need. It offers SENTI-...
Industry Biotechnology
Sector Healthcare
IPO Date May 26, 2021
Employees 39
Stock Exchange NasdaqCM
Ticker Symbol SNTI
Website https://www.sentibio.com
Financial Performance
In 2025, Senti Biosciences s's revenue was 22K, an increase of undefined% compared to the previous year's 0. Earnings were -61.44M, an increase of 16.38%.
Financial StatementsEarnings Surprise
Senti Biosciences s has released their quarterly earnings on Invalid Date:
- Revenue of n/a misses estimates by $0, with NaN% YoY growth.
- EPS of misses estimates by , with NaN% YoY growth.